Neurocrine Biosciences (NBIX) Tops Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 167.39 +22.04 (15.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.35 | 52 Week High | $58.46 | |||
| Open | $159.00 | 52 Week Low | $31.25 | |||
| Day High | $168.47 | P/E | N/A | |||
| Day Low | $157.91 | EPS | $-0.69 | |||
| Volume | 1,887,483 | |||||
